Disclosed is an immunotherapeutic composition comprising IL-17. Also disclosed is a method of increasing the required immune response of subjects. The method can comprise applying the immunotherapeutic composition to subjects. The increased immune response can protect against flu virus. Further disclosed is a method of diagnosing flu virus infection.